Concepedia

Elisabeth Silkenstedt

ES

Statistics

Publications

4

Citations

123

H-Index

4

Active since

2018

Affiliations

Ludwig-Maximilians-Universität München(Current)

Centro de Investigación Biomédica en Red de Cáncer

Robert Bosch Hospital

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Elisabeth Silkenstedt is an author at Ludwig-Maximilians-Universität München specializing in molecular oncology, oncology, and oncogenic signaling pathways.

ORCID

Publications per year

2018–2022

4

Publications

4

Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy

Elisabeth Silkenstedt, Fabián Arenas, Berta Colom-Sanmartí et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 34 citations · Full text

, , +17

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells

Mònica López‐Guerra, Sílvia Xargay‐Torrent, Patricia Fuentes et al. · Oncogene · 2019 · 33 citations · Full text

, , +12

Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA

Simon Heine, Markus Kleih, Neus Giménez et al. · Journal of Hematology & Oncology · 2018 · 28 citations · Full text

, , +17

PARP14 is a novel target in STAT6 mutant follicular lymphoma

Michael Mentz, William Keay, Carolin Dorothea Strobl et al. · Leukemia · 2022 · 28 citations · Full text

, , +17

1–4 of 4